Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe MARLBOROUGH, Mass., Boston Scientific has received United States (U.S.) Food and Drug Administration (FDA) approval ...

Long Beach, Calif. – May 3, 2024 – New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV) demonstrated that catheter-directed mechanical thrombectomy is safe ...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The US-based clinical stage ...

SAN FRANCISCO (MarketWatch) -- Possis Medical Inc. said Monday it has received marketing approval from the Food and Drug Administration for its AngioJet Ultra Thrombectomy System, the next-generation ...

The Recana System is Designed for the Treatment of Venous In-Stent Restenosis and Native Vessel Obstructions REDWOOD CITY, Calif., July 22, 2025--(BUSINESS WIRE)--InterVene, Inc., a medical device ...

The mechanism in the AngioJet rheolytic thrombectomy (RT) system (Figure 1) involves the delivery of pressurized heparinized saline from the catheter, where saline jets travel backwards creating a low ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel ...

Penumbra’s most advanced thrombectomy device, the ACE™68 Reperfusion Catheter, part of the fully integrated Penumbra System®, was launched at the SNIS ...

Inquis Medical has closed its $40m Series B oversubscribed financing round for expediting the advancement of its Aventus Thrombectomy System intended to address venous thromboembolism. This round was ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a medical device company pioneering interventional devices for venous inflow and outflow obstructions, announced today that the first patient ...